ARCHIVES

Perjeta, Herceptin & Docetaxel Combination Extended Survival in HER2-Positive Disease

This article is from The Cancer Letter archive.

Vol. 35 No. 12 | December 28, 2012

Download PDF Visit The Full Archive

Related Articles

Obituary: Eugene Schonfeld, Founder of Kidney Cancer Foundation

October 3, 1997

CT Scanning Use, Costs, Controls Debated By NCAB

October 7, 1977

In Brief: O’Conor Names NCI Liaison To IARC, Saunders Acting IA Director Susan Sieber DCCP Deputy

May 27, 1983

Physicians Not Giving Enough Narcotics For Effective Pain Control, M.D. Anderson Specialist Tells Seminar

April 14, 1989

Federal Coordinating Council On Comparative Effectiveness Research To Hold Meeting

April 10, 2009

NCI Cooperative Group Clinical Trials Approved

February 26, 2010